Inhibikase Therapeutics, Inc. (IKT)

Revenue & Top-Line Growth

Latest Revenue

Financial Fundamentals

IKT • Quarterly Data • 5Y View

Date	Revenue ($B)	QoQ %	YoY %	TTM ($B)	TTM %
2026-03-31	0.00B	—	—	0.00B	—
2025-12-31	0.00B	—	—	0.00B	—
2025-09-30	0.00B	—	—	0.00B	—
2025-06-30	0.00B	—	—	0.00B	—
2025-03-31	0.00B	—	—	0.00B	—
2024-12-31	0.00B	—	—	0.00B	—
2024-09-30	0.00B	—	—	0.00B	-100.0%
2024-06-30	0.00B	—	—	0.00B	-68.4%
2024-03-31	0.00B	—	—	0.00B	+38.1%
2023-12-31	0.00B	-100.0%	-100.0%	0.00B	+111.0%
2023-09-30	0.00B	-31.6%	+991.3%	0.00B	+424.2%
2023-06-30	0.00B	+80.4%	+1676.7%	0.00B	-34.3%
2023-03-31	0.00B	+1.5%	+40.2%	0.00B	-91.8%
2022-12-31	0.00B	+771.8%	+3169.9%	0.00B	-96.0%
2022-09-30	0.00B	+11.3%	-97.8%	0.00B	-98.1%
2022-06-30	0.00B	-85.8%	-99.5%	0.00B	-87.1%
2022-03-31	0.00B	+2267.8%	-96.7%	0.00B	-5.2%
2021-12-31	0.00B	-99.4%	-98.9%	0.00B	+343.9%
2021-09-30	0.00B	-75.9%	+771.7%	0.00B	+325.5%
2021-06-30	0.00B	-3.1%	+520.7%	0.00B	+248.3%
2021-03-31	0.00B	+725.7%	+419.7%	0.00B	+128.7%
2020-12-31	0.00B	+352.3%	-29.1%	0.00B	-37.8%
2020-09-30	0.00B	-82.8%	-69.7%	0.00B	-65.5%
2020-06-30	0.00B	-18.9%	+31.5%	0.00B	-69.4%
2020-03-31	0.00B	+12.7%	-54.2%	0.00B	-76.6%
2019-12-31	0.00B	+93.1%	-82.1%	0.00B	-63.6%
2019-09-30	0.00B	-25.5%	-82.0%	0.00B	—
2019-06-30	0.00B	-71.8%	-79.1%	0.00B	—
2019-03-31	0.00B	-56.1%	+138.9%	0.00B	—
2018-12-31	0.00B	+94.6%	—	0.00B	—
2018-03-31	0.00B	-13.3%	—	0.00B	—
2017-12-31	0.00B	+222.3%	—	0.00B	—
2017-03-31	0.00B	—	—	0.00B	—